is associated with a high rate of long term survival. Accordingly, we have studied the ocular effect of radiotherapy in our patients irradiated for orbital lymphoma.
15 Gy.
The early and late ocular and orbital morbidity in these patients was low. Eight radiation-induced cataracts developed of which only six interfered with vision.
None has needed cataract surgery. No patients developed radiation retinopathy and only 5 had disorders of ocular lubrication.
Most of the previous studies of the effects of X-rays on the eye and orbit have been con cerned with cataract formation1,2 or with the effect of high doses (50 to 70 Gy) admin istered for treatment of adjacent carcinomas of the air sinuses or nasopharynx.3.4.5
The incidence of late ocular and orbital morbidity is high with doses of 50 to 70 Gy; complications include disordered ocular lubri cation, retinopathy and cataract. The inci dence of late ocular and orbital morbidity in patients treated with lower doses in the range of 30 to 40 Gy has not previously been reported, because this dose level is most often used for palliative treatment, for example in patients with orbital and choroidal metastases who do not survive long enough for assessment. However, orbital lymphoma is treated by radiotherapy using this range of dose, and is associated with a high rate of long term survival. Accordingly, we have studied the ocular effect of radiotherapy in our patients irradiated for orbital lymphoma.
Material and Methods
Between January 1970 and December 1984, 115 patients with orbital or conjunctival non-Hodgkin's lymphoma were referred to the ophthalmic clinic at the Royal Marsden Hospital. There were 61 males and 54 females. The median age at diagnosis was 63 years (range 3 to 86 years).
Tumour assessment
The diagnosis was established by biopsy in all cases. The position and extent of the disease in the orbit were ascertained by clinical examination, and since 1975 were delineated by CT scanning.
The patients were examined for evidence of dis seminated lymphoma, in particular looking for signs of lymphadenopathy, hepatosplenomegaly, skin and pharyngeal involvement. All patients had a full blood count and chest X-ray, most had a bone marrow biopsy, and had either bipedal lymphogra phy or a CT scan of the abdomen and pelvis.
On the basis of the clinical findings and results of the above investigations the patients were staged according to the Ann Arbor classification.6
Ophthalmic examination
Visual acuities were measured. External examin ation included measurement of proptosis and assessment of eye movements. Eyes were exam ined before, during and after radiotherapy, using a slit lamp biomicroscope in order to assess changes in either the tear film, cornea or lens. Routine fundus examination was also carried out.
Histology
There are several different classifications of non Hodgkin's lymphoma in current use. In this report the patients are divided into 3 broad groups.
(a) High-grade malignant lymphoma, 18 patients.
(b) Low-grade malignant lymphoma, 44 patients. These were all reported as malignant tumours by at least one pathologist, or had clinical evidence of disseminated disease.
(c) Indeterminate lymphocytic lesions, 53 patients.7 These consist of lymphoid cells, but une quivocal histological features of malignancy are absent.
We regard Group C to be low-grade lymphoma, because they show the same natural history and dissemination pattern as Group B.B There are therefore 97 patients regarded as having low-grade lymphoma, 81 had disease confined to one or both orbits (Stage IE). The tumour was bilateral in 5 patients. Sixteen had disease outside the orbit, (Stage lIE-IV); two of these had a nodular pattern, the remaining 14 were of the diffuse well-differen tiated lymphocytic type.
Treatment
Only 3 patients did not receive radiotherapy to the orbit. One elderly patient with advanced immu noblastic lymphoma received no treatment, and two of the 8 patients with disseminated low-grade lymphoma (Stage IIIE or IV) were treated by chemotherapy alone. Of the 112 patients treated by radiotherapy, 3 of the 18 with high-grade lym phoma and one of the 6 with disseminated lowgrade lymphoma also received chemotherapy as part of their initial management.
Follow-up
Seven patients died within one year of radio therapy, so their late morbidity could not be assessed. Seventy-three patients (70 per cent) have been followed-up for at least one year either at the Ophthalmic Clinic, Royal Marsden Hospital, London (RAFW) or at Moorfields Eye Hospital, London (JEW). There were three main reasons why the assessment of late morbidity was inade quate in 32 patients:
(1) The patient was unwilling to attend a fol low-up clinic mostly because of advanced age.
(2) The patient was referred to a hospital nearer home for follow-up and detailed ophthalmic exam inations were not performed.
(3) The patient came from abroad and did not return sufficiently regularly for examination.
At each follow-up visit ophthalmological examin ation was done as described above. Fundus fluor escein angiography was performed in a randomly selected group of 10 patients who had no lens opacities.
Radiotherapy technique and dose
Patients with localised high-grade lymphoma were treated to a dose of 40 Gy in 20 fractions over a period of 4 weeks. Patients with low-grade lym phoma received 40 Gy in 20 fractions over 4 weeks until 1976, since when a dose of 30 Gy in 15 frac tions in 3 weeks has been given. Our present policy is to treat the whole orbit using megavoltage irra diation, with a field arrangement individually planned for each patient taking into account the clinical and CT findings. The most commonly used technique consisted of a direct anterior field and a lateral field behind the lenses (Fig. 1) . In most cases the cornea and lens were shielded from the anterior radiation field using a pencil-shaped lead block. Where the tumour was confined to the intraconal space lateral fields only were used.
Patients with small conjunctival lesions were generally treated with superficial X-rays (110 or 145 kV) and received 20 to 24 Gy in 1�12 fractions in 2 weeks. Since 1975 CT scanning has been used to confirm that such lesions are limited to the con junctiva. Fifty-nine of the 73 patients who had adequate follow-up were treated with megavoltage X-rays using either anterior and lateral wedged fields or an anterior field alone. The lens dose was calculated for these 59 patients (64 lenses) but not for those treated with other techniques. The method of calculation of lens dose is described elsewhere.s When the corneal shield is used the absorbed dose in the lens is higher at the periphery than at the central zone. The mean lens dose calcu lated at a point estimated to be in the germinative zone was 15 Oy (see Tables I and II ) with a range of 5.5 to 24.50y (see Fig. 2 ) when the shield was used.
Results

Survival
The survival of these patients is described in detail elsewhere. Cataract formation (see Tables I and II and Figs. 2-4) Posterior subcapsular lens opacities were observed in 8 patients. These were all uni lateraL None of the patients who received radiotherapy to both orbits and had adequate follow-up developed a cataract. In 6 of the 8 patients there has been a reduction in visual acuity ( Fig. 3 ) but none so far has needed cataract surgery. In 2 of these patients, catar act formation could have been enhanced by other causes. One had systemic cortico steroids, and one had severe ophthalmic herpes zoster two years after radiotherapy.
Three patients (aged 69, 73 and 73 when treated) have developed senile cortical catar acts whilst being followed-up. These lens changes were not attributed to radiotherapy as they were bilateral and symmetrical, and therefore were probably age related. When the lens was shielded from the anterior radia tion field and the mean lens dose was reduced to 15 Gy (see Tables I and II) , the probability of cataract formation was 12 per cent at 5 years and 28 per cent at 8 years (Table II , Fig. 4 ). The probability of formation of a cat aract reducing visual acuity was 7 per cent at 5 years and 16 per cent at 8 years. When the lens was not shielded and received the full radia tion dose, (30 Gy), the probability of cataract formation with reduction of visual acuity was 64 per cent at 5 years, (Fig. 4) . No lens opacities were observed in patients receiving a lens dose of less than 10 Gy but the follow-up for these patients was shorter than for those receiving a higher dose and further follow-up on these patients is needed.
Disordered ocular lubrication and corneal ulceration
None of the patients receiving an orbital dose of less than 30 Gy complained of a 'dry eye' (see Table III ). Disordered ocular lubrication was recorded as such when the patient was persistently symptomatic after the subsidence of the acute radiation reaction, and had punctate epithelial staining of the cornea, with normal lid-globe apposition and a reduced marginal tear meniscus. The incidence in the dose range 30 to 39 Gy was only 4.5 per cent (two patients). The incidence was 23 per cent (three patients) for those patients receiving 40 to 49 Gy. Only 2 patients developed a corneal ulcer and both of these eventually healed. One patient received 48 Gy to the orbit with 60 Co X-rays but the cornea was shielded. The other received 41 Gy with 250 kV X-rays and there was no corneal shielding. Both patients also had tear film instability, which was prob ably the major aetiological factor in the for mation of the corneal ulcer in the first patient.
Retinopathy
No radiation-induced retinopathy was ob served in any treated eye. No retino-vascular changes were demonstrated in the 10 patients investigated by fundus fluorescein angiogra phy. The retina in these 10 patients had received a radiation dose of 25-30 Gy.
Other Changes
Mild conjunctival telangiectasia has been observed. Asteroid hyalitis was present in two of the treated eyes. This finding was thought to be coincidental.
Effect of chemotherapy on morbidity
There was no late morbidity in the three patients treated with chemotherapy alone. One of the four patients treated with chemo therapy and radiotherapy-a three year old boy with a Stage IE diffuse lymphoblastic lym phoma-developed a cataract. He was treated with chemotherapy and also received 30 Gy to the orbit. Because of extensive orbi tal involvement no corneal shielding was used. The cataract developed two years after treatment and this was thought to be due to radiation rather than to the cortico-steroids used in the chemotherapy protocol.
Discussion
It has been shown2 that irradiation of the central zone of the lens, which has no mitotic activity, does not result in cataract formation. Cataracts form because of irradiation of the germinative zone of the anterior lens epi- Radiation dose to germinative zone of lens (Gy) Fig. 2 . Histogram of distribution of radiation dose to the germinative zone of the lens when anterior lens shielding is used. Five radiation induced cataracts were observed when lens shielding was used and these occurred at doses to the germinative zone of 15 Gy (3 lenses) and 18 Gy and 24 Gy (J lens each).
thelium which is situated peripherally in the lens. Radiation induced cataract has been exten sively studied by Merriam and associates.1.2 Opacities appear centrally in the posterior subcapsular region as small granules or vac uoles forming a doughnut shape with a rela tively clear central part. These changes may or may not progress sufficiently to interfere with vision. The probability of visual impairment, and the latent period between irradiation and development of the cataract, are both depen dent on radiation dose. The higher the radia tion dose the more probable is the progression to a mature cataract, and the shorter the latent period.
A high incidence of cataract from lens dos age above 40 Gy has been confirmed in several studies. Egbert et af.3 reported ocular complications in children with retinoblastoma who were treated with external beam radio therapy; they received 50 to 60 Gy and had a minimum follow-up of two years. Seventy per cent of them developed cataract. Chan and Shukovsky5 found a high incidence of cataract in patients receiving 60 Gy to the lens during treatment for para-nasal sinus tumours. Par sons et al. 4 reviewed late ocular morbidity in 74 patients who received radiotherapy, mostly for para-nasal sinus or nasal cavity tumours, to a dose of 40 to 75 Gy. All of these devel oped a cataract. No attempt was made to cal-LENS OPACITIES F ollow�up 5 -10 years
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Visual acuity after development of lens opacities Fig. 3 . Graph of reduction in visual acuity attributa ble to radiation induced cataract. Circles = shielded lenses Squares = unshielded lenses In one case, where the lens received 30 Gy, subsequent fo llow-up was at another centre. A radiation-induced cataract with slight reduction in vision was observed, but accurate visual acuity measurements were not obtained before death.
cui ate the lens dose in those who had lens shielding. The incidence of cataract formation from lower doses is less clear. From our obser vation of a 64 per cent incidence of cataract by five years in patients receiving a lens dose of 30 Gy, it is likely that almost all who receive this dose will ultimately develop cataract. The effect of doses below 20 Gy is especially con troversial. Merriam and Focht1 estimated lens doses retrospectively in patients treated with X-rays in the kilovoltage range. They found that the lowest dose to produce lens opacities was 2 Gy for a single exposure and 4 Gy for a fractionated course. They claimed that a lens dose greater than 10 Gy in a fractionated course always led ultimately to cataract for mation with an average time of onset of 4 or 5 years. However, not all patients receiving lens irradiation during the period of the survey were examined, and the number of patients who received fractionated radiotherapy in each range of lens dose was small.
Deeg et a[.9 studied the incidence of catar act formation in 277 patients undergoing bone marrow transplantation. These patients received whole body irradiation without lens shielding. After a single exposure of 10 Gy 70 per cent developed a cataract within five years. The probability of cataract formation in those patients receiving a fractionated dose of 12 to 16 Gy and who had not received cortico steroids was 9 per cent at 5 years. This agrees with our figures of 12 per cent for lenses receiving a mean dose of 15 Gy. It is possible that the risk of cataract formation from doses in this range has been previously over estimated .
Disordered ocular lubrication
Tears are composed of a superficial lipid layer, an aqueous middle layer, and a deep mucinous layer. The stability of the normal tear film is dependent on the presence of normal epithelial microvilli with adherent brush-like glycoproteins, which originate from sub-surface epithelial vesicles. Parsons et al. 4 found that all patients receiving more than 50 Gy to the orbit developed a 'dry eye' but that the majority who received 30 to 40 Gy did not do so. Roth et al. lO in a study of the effects of fast neutrons on the eye found that fractionated doses of 220 to 860 neutron rad (approximately equivalent to 8 to 30 Gy of fractionated X-rays) led to tear-oil deficiency and corneal drying as a result of meibomian gland obliteration. Tear-film deficiency occurred mostly at doses equivalent to 40 Gy or greater of fractionated X-rays.
Our findings are broadly in agreement with these previous studies. No patient who received less than 30 Gy to the orbit devel oped disordered ocular lubrication and the incidence in those receiving 30 to 39 Gy was only 4.5 per cent (Table III) . Inadequate ocular lubrication following radiotherapy may result from either radiation-induced ocular surface disease or radiation-induced lacrimal gland abnormalities or a combination of both. Corneal ulceration may' result from corneal drying, reduced sensation and radiation induced ocular surface disease. Only two patients developed a small anterior stromal corneal ulcer which eventually healed. Both of these patients received over 40 Gy to the orbit.
Retinopathy
The effects of radiation on the retina have been described by several authors.3,4,1l The changes appear between 1.5 and 2 years after treatment. The main change is telangiectasia but capillary obstruction and micro aneurysms also occur. Parsons et al. 4 described severe radiation retinopathy in 12 of 13 patients receiving 50 to 70 Gy over 5 to 9 weeks. At radiation doses of 50 to 60 Gy to the retina, fine and coarse pigment mottling with occasional micro aneurysms occur.3 A dose of 80 Gy to the retina (which for example, may result from the application of 60 Co plaques for the treatment of choroidal malignant melanoma) causes more severe retinal damage. Fluorescein leakage from telangiec tatic vessels is seen at angiography and some patient have infarcts, haemorrhages and exu dates.ll No retinopathy was observed in any of our patients. Of the 10 patients examined by fundus fluorescein angiography, who received a retinal dose of 25 to 30 Gy, no retino-vascular changes were detected. These results sug gest that the risk of retinopathy with this dose of radiation is very small.
Conclusions
Orbital lymphoma can be successfully treated by moderate doses of radiotherapy (30 to 40 Gy). In most cases the lens can be partially shielded from radiation and can receive 10 to 15 Gy. At these dose levels early and late ocular morbidity caused by radiotherapy is slight, in contrast to the effects of higher doses of radiation (50 to 70 Gy) which usually lead to disordered ocular lubrication, cataract and retinopathy.
